Discover how GT19630, a novel molecular glue, targets the previously undruggable MYC oncoprotein in cancer treatment through protein degradation.
Exploring the molecular drivers of angiosarcoma - aberrant angiogenic signaling and MYC amplifications - and their implications for targeted therapies.